Atrial fibrillation and stroke prevention: state of the art-epidemiology and pathophysiology: new risk factors, concepts and controversies

被引：12

作者：

Kodani, Eitaro ^{[1
]}

Akao, Masaharu ^{[2
]}

机构：

[1] Tama Nagayama Hosp, Dept Cardiovasc Med, Nippon Med Sch, 1-7-1 Nagayama, Tama, Tokyo 2068512, Japan

[2] Natl Hosp Org Kyoto Med Ctr, Dept Cardiol, Fushimi Ku, 1-1 Mukaihata Cho, Kyoto 6128555, Japan

来源：

EUROPEAN HEART JOURNAL SUPPLEMENTS | 2020年 / 22卷 / 0O期

关键词：

atrial fibrillation; Stroke; risk factor; epidemiology; pathophysiology; SYSTOLIC BLOOD-PRESSURE; VALVULAR HEART-DISEASE; JAPANESE PATIENTS; PREDICTING STROKE; BLEEDING RISK; ANTICOAGULATED PATIENTS; SYSTEMIC EMBOLISM; ISCHEMIC-STROKE; ANTITHROMBOTIC THERAPY; ORAL ANTICOAGULANTS;

D O I：

10.1093/eurheartj/suaa176

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation (AF) increases the risk of thromboembolism, and risk assessment for thromboembolism is necessary for the management of AF patients. CHADS2 and CHA2DS2-VASc scores have been adopted in international guidelines for AF management, but the significance of each risk factor included in these risk scores are sometimes controversial, and the performance of these scores is only modest. There are several other risk factors not included in the scores such as renal dysfunction, low body weight, type of AF (paroxysmal or non-paroxysmal) as well as echocardiographic parameters and blood biomarkers, and physicians should assess patientsa risk in an integrated manner.

引用

页码：1 / 13

页数：13

共 50 条

[1] Stroke Prevention in Atrial Fibrillation: Concepts and Controversies
Ahmad, Yousif
Lip, Gregory Y. H.
[J]. CURRENT CARDIOLOGY REVIEWS, 2012, 8 (04) : 290 - 301
[2] Atrial fibrillation and stroke - Concepts and controversies
Hart, RG
Halperin, JL
[J]. STROKE, 2001, 32 (03) : 803 - 808
[3] Stroke prevention in atrial fibrillation: State of the art
Li, Yan-Guang
Lip, Gregory Y. H.
[J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 287 : 201 - 209
[4] The State of the Art: Atrial Fibrillation Epidemiology, Prevention, and Treatment
Morin, Daniel P.
Bernard, Michael L.
Madias, Christopher
Rogers, Paul A.
Thihalolipavan, Sudarone
Estes, N. A. Mark, III
[J]. MAYO CLINIC PROCEEDINGS, 2016, 91 (12) : 1778 - 1810
[5] ATRIAL-FIBRILLATION - EPIDEMIOLOGY AND THE RISK AND PREVENTION OF STROKE
KALMAN, JM
TONKIN, AM
[J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1992, 15 (09): : 1332 - 1346
[6] Atrial fibrillation and stroke: More concepts and controversies
Conway, D
Lip, GYH
[J]. STROKE, 2001, 32 (08) : 1931 - 1931
[7] Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
Ding, Wern Yew
Harrison, Stephanie
Gupta, Dhiraj
Lip, Gregory Y. H.
Lane, Deirdre A.
[J]. FRONTIERS IN MEDICINE, 2020, 7
[8] Atrial fibrillation and stroke: Epidemiology, pathophysiology, and management
Anderson, DC
Koller, RL
Asinger, RW
Bundlie, SR
Pearce, LA
[J]. NEUROLOGIST, 1998, 4 (05) : 235 - 258
[9] Risk Factors for Stroke and Primary Prevention of Stroke in Atrial Fibrillation
Andreas Laupacis
Daniel Singer
Alan Jacobsen
Marvin Dunn
Jim Dalen
Greg Albers
[J]. Journal of Thrombosis and Thrombolysis, 1999, 7 : 21 - 26
[10] Risk factors for stroke and primary prevention of stroke in atrial fibrillation
Laupacis, A
Singer, D
Jacobsen, A
Dunn, M
Dalen, J
Albers, G
[J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 1999, 7 (01) : 21 - 26

← 1 2 3 4 5 →